Monashee Investment Management LLC
Investor profile
Monashee Investment Management LLC has backed 2 European tech companies across 2 funding rounds in 2021, joining rounds totalling €343M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2021
1 yr
Total round €
€343M
sum of rounds joined
Deals by year
distinct rounds / yearMonashee Investment Management LLC — deals by year — interactive chart.
Data table
| Monashee Investment Management LLC — deals by year | |
|---|---|
| 2021 | 2 |
Top sectors
by dealsMonashee Investment Management LLC — top sectors — interactive chart.
Data table
| Monashee Investment Management LLC — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsMonashee Investment Management LLC — stages — interactive chart.
Data table
| Monashee Investment Management LLC — stages | |
|---|---|
| Series B | 1 |
| Series D+ | 1 |
Countries
by dealsMonashee Investment Management LLC — countries — interactive chart.
Data table
| Monashee Investment Management LLC — countries | |
|---|---|
| UK | 2 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Ancora Finance Group1
- BlackRock1
- British Patient Capital1
- Eldridge1
- Fidelity Management & Research Company LLC1
- Glenview Capital1
- Janus Henderson Investors1
- Jeito Capital1
- Millennium Venture Capital1
- Novo Holdings1
- Orlando Health1
- Point72 Ventures1
- Puhua Capital1
- Ridgeback Capital Investments1
- Sands Capital Ventures1
- Segulah Medical1
- SV Health Investors1
- Syncona Partners1
- Tekla Capital Management1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quanta | UK | 1 | €205M |
| Quell Therapeutics | UK | 1 | €138M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quanta | Series D+ | €205M | 2021-06 |
| Quell Therapeutics | Series B | €138M | 2021-11 |